Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies.

about

Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.Current Concepts and Treatments of Schizophrenia

P2860

Q47162951-2C9BED95-52F1-4D99-9E9F-BB3E959D47C0 Q55232340-3F35084E-AF30-40B0-B587-FBB5DE39DA66 Q58693044-A285810D-1011-4183-8750-A519EC323581

P2860

Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies.

Item

http://www.wikidata.org/entity/Q39353717

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Second-Generation Antipsychoti ...... w of Population-Based Studies.

@en

Second-Generation Antipsychoti ...... w of Population-Based Studies.

@nl

type

Item

label

Second-Generation Antipsychoti ...... w of Population-Based Studies.

@en

Second-Generation Antipsychoti ...... w of Population-Based Studies.

@nl

prefLabel

Second-Generation Antipsychoti ...... w of Population-Based Studies.

@en

Second-Generation Antipsychoti ...... w of Population-Based Studies.

@nl

P1476

Second-Generation Antipsychoti ...... w of Population-Based Studies.

@en

P2093

Jaeun Yang

http://www.w3.org/2001/XMLSchema#string

Lauren Bresee

http://www.w3.org/2001/XMLSchema#string

Tamara Pringsheim

http://www.w3.org/2001/XMLSchema#string

P2860

Aripiprazole versus other atypical antipsychotics for schizophrenia

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.

Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities.

Systematic review of the efficacy and tolerability of clozapine in the treatment of youth with early onset schizophrenia.

Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study.

AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews.

Incident users of antipsychotic agents and future use of cholesterol-lowering drugs: an observational, pharmacoepidemiologic study.

Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths.

Treatment with antipsychotics and the risk of diabetes in clinical practice.

P2888

s40264-017-0543-0

P31

scholarly article

P356

10.1007/S40264-017-0543-0

http://www.w3.org/2001/XMLSchema#string

P50

Scott B. Patten

Lauren Hirsch

Nathalie Jetté

P577

2017-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28585153

http://www.w3.org/2001/XMLSchema#string

Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies.

about

P2860

P2860

Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P50

P577

P698